R S Walters

Medicine · Health Sciences

18h-index2.8kcitations29works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(9), Acute Myeloid Leukemia Research(8), Acute Lymphoblastic Leukemia research(6), Chronic Lymphocytic Leukemia Research(4), Chronic Myeloid Leukemia Treatments(4)

Publications29 total

110 The trigger project: introducing electronic patient reported outcome measures into radiotherapy services
Poster·2019Open Access
The Trigger Project: The Challenge of Introducing Electronic Patient-Reported Outcome Measures Into a Radiotherapy Service
Clinical Oncology·2019· 12 citedOpen Access
Phase III study of docetaxel weekly (DW) versus every 3 weeks (D) in patients with metastatic breast cancer: Final results
Journal of Clinical Oncology·2006· 5 cited
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results
Annals of Oncology·1999· 23 citedOpen Access
Daily Oral Etoposide in Patients With Heavily Pretreated Metastatic Breast Cancer
American Journal of Clinical Oncology·1998· 23 cited
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
Journal of Clinical Oncology·1996· 166 cited
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
Journal of Clinical Oncology·1995· 387 cited
Phase II study of taxotere in refractory metastatic breast cancer (RMBC)
European Journal of Cancer·1993· 16 cited
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
JNCI Journal of the National Cancer Institute·1991· 745 cited
Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
Journal of Clinical Oncology·1991· 42 cited
Pirarubicin in Combination Chemotherapy for Metastatic Breast Cancer
American Journal of Clinical Oncology·1990· 5 cited
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.
Journal of Clinical Oncology·1990· 170 cited
Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
PubMed·1989· 59 cited
Response to salvage therapy and survival after relapse in acute myelogenous leukemia.
Journal of Clinical Oncology·1989· 174 cited
STATISTICAL ESTIMATION OF ROLLOVER RISK
1989· 14 cited
Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancy.
PubMed·1988· 6 cited
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.
PubMed·1988· 218 cited
Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor
Blood·1988· 132 citedOpen Access
Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor
Blood·1988· 8 citedOpen Access
The characteristics and outcome of patients with late relapse acute myelogenous leukemia.
Journal of Clinical Oncology·1988· 84 cited
page 1 of 2Next →

Frequent Co-authors

Michael J. Keating(7), Vicente Valero(6), Giuseppe Fraschini(6), Terry L. Smith(6), G. N. Hortobágyi(5), Hagop M. Kantarjian(5), Emil J. Freireich(5), Gutterman Ju(5), Frankie A. Holmes(4), R. Theriault(4), Gabriel N. Hortobágyi(4), K. B. McCredie(4), Elihu H. Estey(4), D. Frye(3), Richard L. Theriault(3), Saroj Vadhan‐Raj(3), Razelle Kurzrock(3), Moshe Talpaz(3), A. U. Buzdar(2), Leticia Esparza(2)